Pure Global AI
NCT06374420Completed

Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome

Mansoura UniversityClinicalTrials.gov
Verified
Study focus
Disease/Condition
COVID-19
Study type
Observational
Sponsor & location
Primary sponsor
Mansoura University
Location
Mansoura, Egypt
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2021
End date
Apr 01, 2024
Enrollment
100 participants
Primary outcome

investigating pulmonary sequelae of covid-19.,investigating pulmonary sequelae of covid-19.

Summary

The aim of this work is to estimate the frequency of small airway disease and/or the
 bronchial hyperreactivity in follow up of postacute covid survivors.

ICD-10 classifications
COVID-19, virus identifiedCOVID-19, virus not identifiedCoronavirus infection, unspecified siteViral infection, unspecifiedRift Valley fever
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06374420
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06374420 through Pure Global AI's free database. This phase not specified trial is sponsored by Mansoura University and is currently Completed. The study focuses on COVID-19. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.